Stronger Sell Today ACOR ranks #5077 as SELL CANDIDATE #5077 Weaker Sell

ACOR stock forecast Acorda Therapeutics

ACOR stock forecast

Friday December 13, 2019 Change -4.35% Price $1.76
Your prediction: Prediction: Request
VOLUME
Sell
TREND
Sell
MV LONG
Sell

MV SHORT
Buy

PIVOT
Sell

MACD
Buy

ACOR Forecast and Technical Stock Analysis


Sell candidate since 2019-12-13 PDF

Acorda Therapeutics fell by -4.35% in the last day ( Friday, 13th Dec 2019 ) from $1.84 to $1.76 During the day the stock fluctuated 10.34% from a day low at $1.74 to a day high of $1.92. The price has risen in 6 of the last 10 days and is up by 10% over the past 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -0.67 million shares and in total 1.16 million shares bought and sold for approximately $2.04 million.

Quick summary:

  • 30 day high of the ACOR stock price was $2.18 and low was $1.49.
  • 90 day high was $4.04 and low was $1.49.
  • 52 week high for Acorda Therapeutics - $17.57 and low - $1.49.
Top Trending Stocks

Trend

Acorda Therapeutics lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $1.89 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -49.24% during the next 3 months and, with 90% probability hold a price between $0.39 and $0.96 at the end of this period.

Top Golden Star Stocks

Signals

Some negative signals were issued as well, and these may have some influence on the near short-term development. Acorda Therapeutics holds a buy signal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $1.87. On a fall, the stock will find some support from the short-term average at $1.74. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. A sales signal was issued from a pivot top point on Thursday December 12, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSImin/max Values: [ 25 - 75 ]

RSI14 is 46 and the stock is currently not being overbought or oversold

* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.

Support & Resistance

Acorda Therapeutics finds support from accumulated volume at $1.75.

Support: $1.75 Price: $1.76 Resistance: $1.83

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.18 between high and low, or 10.34%. For the last week, the stock has had a daily average volatility of 9.33%.

Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.

9.33 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Sell Candidate Downgraded

Evaluation

Acorda Therapeutics holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since last evaluation from a Hold/Accumulate to a Sell Candidate candidate.

Stronger Sell Today ACOR ranks #5077 as SELL CANDIDATE #5077 Weaker Sell
Exchange: NASDAQ | NYSE | XLON | AMS | TSX | BRU

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

Proudly made at

ROCKIT